Anti-apoptotic Peptide for Long Term Cardioprotection in a Mouse Model of Myocardial Ischemia-reperfusion Injury

Overview

Journal Sci Rep

Specialty Science

Date 2020 Oct 23

PMID 33093627

Citations 5

Authors

Aurelie Covinhes

Laura Gallot

Christian Barrere

Anne Vincent

Catherine Sportouch

Christophe Piot

Bernard Lebleu

Joel Nargeot

Prisca Boisguerin

Stephanie Barrere-Lemaire

Affiliations

Soon will be listed here.

Abstract

Reperfusion therapy during myocardial infarction (MI) leads to side effects called ischemia-reperfusion (IR) injury for which no treatment exists. While most studies have targeted the intrinsic apoptotic pathway to prevent IR injury with no successful clinical translation, we evidenced recently the potent cardioprotective effect of the anti-apoptotic Tat-DAXXp (TD) peptide targeting the FAS-dependent extrinsic pathway. The aim of the present study was to evaluate TD long term cardioprotective effects against IR injury in a MI mouse model. TD peptide (1 mg/kg) was administered in mice subjected to MI (TD; n = 21), 5 min prior to reperfusion, and were clinically followed-up during 6 months after surgery. Plasma cTnI concentration evaluated 24 h post-MI was 70%-decreased in TD (n = 16) versus Ctrl (n = 20) mice (p***). Strain echocardiography highlighted a 24%-increase (p****) in the ejection fraction mean value in TD-treated (n = 12) versus Ctrl mice (n = 17) during the 6 month-period. Improved cardiac performance was associated to a 54%-decrease (p**) in left ventricular fibrosis at 6 months in TD (n = 16) versus Ctrl (n = 20). In conclusion, targeting the extrinsic pathway with TD peptide at the onset of reperfusion provided long-term cardioprotection in a mouse model of myocardial IR injury by improving post-MI cardiac performance and preventing cardiac remodeling.

Citing Articles

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Vitale I, Pietrocola F, Guilbaud E, Aaronson S, Abrams J, Adam D Cell Death Differ. 2023; 30(5):1097-1154.

PMID: 37100955 PMC: 10130819. DOI: 10.1038/s41418-023-01153-w.

PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury.

Sarre C, Contreras-Lopez R, Nernpermpisooth N, Barrere C, Bahraoui S, Terraza C Stem Cell Res Ther. 2022; 13(1):167.

PMID: 35461240 PMC: 9034535. DOI: 10.1186/s13287-022-02840-0.

Therapeutic Peptides to Treat Myocardial Ischemia-Reperfusion Injury.

Fernandez Rico C, Konate K, Josse E, Nargeot J, Barrere-Lemaire S, Boisguerin P Front Cardiovasc Med. 2022; 9:792885.

PMID: 35252383 PMC: 8891520. DOI: 10.3389/fcvm.2022.792885.

Faster skin wound healing predicts survival after myocardial infarction.

Becirovic-Agic M, Chalise U, Jung M, Rodriguez-Paar J, Konfrst S, Flynn E Am J Physiol Heart Circ Physiol. 2022; 322(4):H537-H548.

PMID: 35089808 PMC: 8917917. DOI: 10.1152/ajpheart.00612.2021.

PPARβ/δ Is Required for Mesenchymal Stem Cell Cardioprotective Effects Independently of Their Anti-inflammatory Properties in Myocardial Ischemia-Reperfusion Injury.

Nernpermpisooth N, Sarre C, Barrere C, Contreras R, Luz-Crawford P, Tejedor G Front Cardiovasc Med. 2021; 8:681002.

PMID: 34616778 PMC: 8488150. DOI: 10.3389/fcvm.2021.681002.

References

Boisguerin P, Redt-Clouet C, Franck-Miclo A, Licheheb S, Nargeot J, Barrere-Lemaire S . Systemic delivery of BH4 anti-apoptotic peptide using CPPs prevents cardiac ischemia-reperfusion injuries in vivo. J Control Release. 2011; 156(2):146-53. DOI: 10.1016/j.jconrel.2011.07.037. View

Chen L, Hahn H, Wu G, Chen C, Liron T, Schechtman D . Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A. 2001; 98(20):11114-9. PMC: 58692. DOI: 10.1073/pnas.191369098. View

Song J, Lee Y . Role of the ASK1-SEK1-JNK1-HIPK1 signal in Daxx trafficking and ASK1 oligomerization. J Biol Chem. 2003; 278(47):47245-52. DOI: 10.1074/jbc.M213201200. View

Yang X, Khosravi-Far R, Chang H, Baltimore D . Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell. 1997; 89(7):1067-76. PMC: 2989411. DOI: 10.1016/s0092-8674(00)80294-9. View

Roubille F, Franck-Miclo A, Covinhes A, Lafont C, Cransac F, Combes S . Delayed postconditioning in the mouse heart in vivo. Circulation. 2011; 124(12):1330-6. DOI: 10.1161/CIRCULATIONAHA.111.031864. View

Yang R, Hu K, Chen J, Zhu S, Li L, Lu H . Necrostatin-1 protects hippocampal neurons against ischemia/reperfusion injury via the RIP3/DAXX signaling pathway in rats. Neurosci Lett. 2017; 651:207-215. DOI: 10.1016/j.neulet.2017.05.016. View

Hallen J . Troponin for the estimation of infarct size: what have we learned?. Cardiology. 2012; 121(3):204-12. DOI: 10.1159/000337113. View

Leitman M, Lysyansky P, Sidenko S, Shir V, Peleg E, Binenbaum M . Two-dimensional strain-a novel software for real-time quantitative echocardiographic assessment of myocardial function. J Am Soc Echocardiogr. 2004; 17(10):1021-9. DOI: 10.1016/j.echo.2004.06.019. View

OBrien P . Cardiac troponin is the most effective translational safety biomarker for myocardial injury in cardiotoxicity. Toxicology. 2008; 245(3):206-18. DOI: 10.1016/j.tox.2007.12.006. View

10.

Supavekin S, Zhang W, Kucherlapati R, Kaskel F, Moore L, Devarajan P . Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 2003; 63(5):1714-24. DOI: 10.1046/j.1523-1755.2003.00928.x. View

11.

Mathers C, Loncar D . Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006; 3(11):e442. PMC: 1664601. DOI: 10.1371/journal.pmed.0030442. View

12.

Bauer M, Cheng S, Jain M, Ngoy S, Theodoropoulos C, Trujillo A . Echocardiographic speckle-tracking based strain imaging for rapid cardiovascular phenotyping in mice. Circ Res. 2011; 108(8):908-16. PMC: 3376717. DOI: 10.1161/CIRCRESAHA.110.239574. View

13.

Zhao Z, Velez D, Wang N, Nakamura M, Guyton R, Vinten-Johansen J . Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis. 2001; 6(4):279-90. DOI: 10.1023/a:1011335525219. View

14.

White H, Norris R, Brown M, Brandt P, Whitlock R, Wild C . Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation. 1987; 76(1):44-51. DOI: 10.1161/01.cir.76.1.44. View

15.

Hataishi R, Rodrigues A, Neilan T, Morgan J, Buys E, Shiva S . Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2006; 291(1):H379-84. DOI: 10.1152/ajpheart.01172.2005. View

16.

Zhao Z, Nakamura M, Wang N, Wilcox J, Shearer S, Ronson R . Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res. 2000; 45(3):651-60. DOI: 10.1016/s0008-6363(99)00354-5. View

17.

Travers J, Kamal F, Robbins J, Yutzey K, Blaxall B . Cardiac Fibrosis: The Fibroblast Awakens. Circ Res. 2016; 118(6):1021-40. PMC: 4800485. DOI: 10.1161/CIRCRESAHA.115.306565. View

18.

Antman E, Tanasijevic M, Thompson B, Schactman M, McCabe C, Cannon C . Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996; 335(18):1342-9. DOI: 10.1056/NEJM199610313351802. View

19.

Braunwald E . Myocardial reperfusion, limitation of infarct size, reduction of left ventricular dysfunction, and improved survival. Should the paradigm be expanded?. Circulation. 1989; 79(2):441-4. DOI: 10.1161/01.cir.79.2.441. View

20.

Hung C, Verma A, Uno H, Shin S, Bourgoun M, Hassanein A . Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am Coll Cardiol. 2010; 56(22):1812-22. DOI: 10.1016/j.jacc.2010.06.044. View